[HTML][HTML] CRISPR/dCAS9-mediated DNA demethylation screen identifies functional epigenetic determinants of colorectal cancer

JR Tejedor, A Peñarroya, J Gancedo-Verdejo… - Clinical …, 2023 - Springer
Background Promoter hypermethylation of tumour suppressor genes is frequently observed
during the malignant transformation of colorectal cancer (CRC). However, whether this …

Regulation of protein complex partners as a compensatory mechanism in aneuploid tumors

G Senger, S Santaguida, MH Schaefer - Elife, 2022 - elifesciences.org
Aneuploidy, a state of chromosome imbalance, is a hallmark of human tumors, but its role in
cancer still remains to be fully elucidated. To understand the consequences of whole …

Pancancer analyses reveal genomics and clinical characteristics of the SETDB1 in human tumors

X Lin, M Xiao, Z Chen, C Ding, T Zhang… - Journal of …, 2022 - Wiley Online Library
Background. Malignant tumor is one of the most common diseases that seriously affect
human health. The prior literature has reported the biological function and potential …

Differences in the molecular organisation of tumours along the colon are linked to interactions within the tumour ecosystem

T Dallavilla, S Galiè, G Sambruni, S Borin… - … et Biophysica Acta (BBA …, 2024 - Elsevier
Tumours exhibit significant heterogeneity in their molecular profiles across patients, largely
influenced by the tissue of origin, where certain driver gene mutations are predominantly …

Precise subtyping reveals immune heterogeneity for hormone receptor-positive breast cancer

M Zhang, X Zhang, T Ma, C Wang, J Zhao, Y Gu… - Computers in Biology …, 2023 - Elsevier
A significant proportion of breast cancer cases are characterized by hormone receptor
positivity (HR+). Clinically, the heterogeneity of HR+ breast cancer leads to different …

Genome wide exploration of the methylome in aggressive B-cell lymphoma in Golden Retrievers reveals a conserved hypermethylome

S Chu, A Avery, J Yoshimoto, JN Bryan - Epigenetics, 2022 - Taylor & Francis
Few recurrent DNA mutations are seen in aggressive canine B cell lymphomas (cBCL),
suggesting other frequent drivers. The methylated island recovery assay (MIRA-seq) or …

Revealing cancer driver genes through integrative transcriptomic and epigenomic analyses with Moonlight

M Nourbakhsh, Y Zheng, H Noor, M Tiberti, O Gevaert… - bioRxiv, 2024 - biorxiv.org
Cancer involves dynamic changes caused by (epi) genetic alterations such as mutations or
abnormal DNA methylation patterns which occur in cancer driver genes. These driver genes …

Epigenome editing in cancer: Advances and challenges for potential therapeutic options.

SW Lee, CM Frankston, J Kim - International Review of Cell and …, 2023 - europepmc.org
Cancers are diseases caused by genetic and non-genetic environmental factors. Epigenetic
alterations, some attributed to non-genetic factors, can lead to cancer development …

CAUSES OF ANEUPLOIDY IN TUMOURS AND THE CONSEQUENCES ON GENE EXPRESSION AND PROTEIN COMPLEX STOICHIOMETRY

G Senger - 2024 - air.unimi.it
Protein complexes are dynamic assemblies in which proteins bind each other in different
physiological cell conditions and stoichiometries to perform cellular functions. Failures in …

[HTML][HTML] DNA Methylation Dynamics and Human Diseases

C Jiang, S Li - Frontiers in cell and developmental biology, 2022 - frontiersin.org
DNA methylation is a biological process that adds methyl groups to DNA molecules. It
regulates chromatin architecture and transcription, and plays essential roles in a wide range …